title: The effect of lipoproteins on human glioblastoma growth in vitro.
abstract: Experiments were performed using an established human glioblastoma cell line to determine the effect of lipoproteins on regulating their growth. It was found that synthetic and natural human high density lipoproteins (HDL) were effective in inhibiting tumor cell growth in a nontoxic, dose-dependent manner, and that the LD50 was 10-fold lower than that for normal rat astrocytes grown under identical conditions. In the presence of the antioxidant, glutathione, essentially all of the growth-inhibiting properties of HDL could be reversed suggesting that oxidized lipids from the HDL interacting with the plasma membranes of the glioblastoma cells were responsible for the growth-inhibiting effect observed. The markedly lower concentration of HDL required to inhibit glioblastoma cells in culture compared to normal astrocytes suggested that the mechanism of HDL-induced inhibition may be important for tumor growth in vivo. One possible mechanism under investigation is the possibility of HDL modulation of a membrane-associated, tumor-specific phosphatase.
authors.affiliation: Chicago Institute for Neurosurgery and Neuroresearch, IL 60614.
authors.forename: J R
authors.initials: JR
authors.lastname: Moskal
authors.forename: M
authors.initials: M
authors.lastname: Sinnett
authors.forename: P L
authors.initials: PL
authors.lastname: Kornblith
authors.forename: P
authors.initials: P
authors.lastname: LaSala
authors.forename: D M
authors.initials: DM
authors.lastname: Levine
authors.forename: T S
authors.initials: TS
authors.lastname: Parker
authors.forename: H
authors.initials: H
authors.lastname: Lander
mesh_terms: D016632:Apolipoprotein A-I / Q000494:pharmacology; D016633:Apolipoprotein A-II / Q000494:pharmacology; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D005910:Glioma; D005978:Glutathione / Q000494:pharmacology; D007700:Kinetics; D008074:Lipoproteins / Q000494:pharmacology*; D008075:Lipoproteins, HDL / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
chemical_list: D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D005978:Glutathione